| 000 | 01895 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516163455.0 | ||
| 264 | 0 | _c20140428 | |
| 008 | 201404s 0 0 eng d | ||
| 022 | _a1347-5215 | ||
| 024 | 7 |
_a10.1248/bpb.b13-00272 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShan, Yong-Qiang | |
| 245 | 0 | 0 |
_aTetrandrine potentiates the hypoglycemic efficacy of berberine by inhibiting P-glycoprotein function. _h[electronic resource] |
| 260 |
_bBiological & pharmaceutical bulletin _c2013 |
||
| 300 |
_a1562-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aBenzylisoquinolines _xpharmacology |
| 650 | 0 | 4 |
_aBerberine _xpharmacokinetics |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 | _aCaco-2 Cells |
| 650 | 0 | 4 | _aCytochrome P-450 CYP3A Inhibitors |
| 650 | 0 | 4 |
_aDiabetes Mellitus _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aHep G2 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacokinetics |
| 650 | 0 | 4 |
_aIntestinal Mucosa _xmetabolism |
| 650 | 0 | 4 | _aMCF-7 Cells |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred ICR |
| 650 | 0 | 4 | _aPhytotherapy |
| 650 | 0 | 4 |
_aPlant Extracts _xpharmacology |
| 650 | 0 | 4 |
_aRhodamine 123 _xmetabolism |
| 650 | 0 | 4 |
_aStephania _xchemistry |
| 700 | 1 | _aZhu, Yan-Ping | |
| 700 | 1 | _aPang, Jing | |
| 700 | 1 | _aWang, Yan-Xiang | |
| 700 | 1 | _aSong, Dan-Qing | |
| 700 | 1 | _aKong, Wei-Jia | |
| 700 | 1 | _aJiang, Jian-Dong | |
| 773 | 0 |
_tBiological & pharmaceutical bulletin _gvol. 36 _gno. 10 _gp. 1562-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1248/bpb.b13-00272 _zAvailable from publisher's website |
| 999 |
_c22984683 _d22984683 |
||